Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Factbox-GSK's consumer health business

Published 15/01/2022, 14:48
Updated 15/01/2022, 14:51
© Reuters. FILE PHOTO: The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke MacGregor

© Reuters. FILE PHOTO: The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke MacGregor

(Reuters) - Consumer goods giant Unilever (LON:ULVR) has approached GlaxoSmithKline about buying the pharmaceutical group's consumer goods arm, after a newspaper reported that a 50 billion-pound ($68.4 billion) bid it made had been rebuffed.

GSK declined to comment on the approach which would be an alternative to its plans to list the business separately on the London Stock Exchange this year.

BRANDS:

The consumer goods business, in which U.S. pharmaceuticals company Pfizer (NYSE:PFE) owns a 32% stake, includes brands such as Sensodyne and parodontax toothpaste, painrelief treatments Advil, Voltaren and Panadol, Otrivin nasal spray, cold and flu medicine Theraflu and Centrum vitamins.

GSK and Pfizer folded together their consumer health businesses in a deal completed in 2019.

GSK had struck a $13 billion deal the previous year to buy full control of a consumer health venture with Swiss drugs group Novartis.

MAIN MARKETS:

GSK describes itself as are one of the world's leading over-the-counter (OTC) healthcare companies with number one positions in markets including the United States, India and Germany.

Its rivals include Johnson & Johnson (NYSE:JNJ), Bayer (DE:BAYGN) and Sanofi (PA:SASY).

TURNOVER:

The business generated sales of 10 billion pounds ($13.7 billion) in 2020.

GSK, whose two other main divisions are pharmaceuticals and vaccines, had turnover of 34 billion pounds that year.

MANAGEMENT:

Dave Lewis, former chief executive of British supermarket group Tesco (LON:TSCO), has been appointed to chair the business when it is spun off.

Brian McNamara will be its chief executive, a position he has held since 2016 within the business as part of GSK.

© Reuters. FILE PHOTO: The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke MacGregor

The demerged company is planning to build a new headquarters at Weybridge in southern England.

($1 = 0.7314 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.